VVP technologies include over a dozen patented drug delivery systems, novel nanoformulations and combination therapeutics that target the underlying mechanisms of disease initiation and progression. We hold numerous United States and international patents related to novel modalities and combined therapeutics in the areas of ophthamalogical disorders, vascular disease and cancer.